Stéphane Paul

10.0k total citations
225 papers, 5.5k citations indexed

About

Stéphane Paul is a scholar working on Immunology, Genetics and Epidemiology. According to data from OpenAlex, Stéphane Paul has authored 225 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Immunology, 80 papers in Genetics and 70 papers in Epidemiology. Recurrent topics in Stéphane Paul's work include Inflammatory Bowel Disease (68 papers), Microscopic Colitis (44 papers) and Immunotherapy and Immune Responses (34 papers). Stéphane Paul is often cited by papers focused on Inflammatory Bowel Disease (68 papers), Microscopic Colitis (44 papers) and Immunotherapy and Immune Responses (34 papers). Stéphane Paul collaborates with scholars based in France, United States and United Kingdom. Stéphane Paul's co-authors include Xavier Roblin, Christian Genin, Laurent Peyrin‐Biroulet, Bernard Verrier, Émilie Del Tedesco, Nicolas Rochereau, Jean–Marc Phelip, Vincent Pavot, Hubert Marotte and A Moreau and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Stéphane Paul

207 papers receiving 5.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stéphane Paul 2.2k 2.2k 2.0k 1.1k 590 225 5.5k
Miles Parkes 2.8k 1.3× 1.7k 0.8× 1.5k 0.8× 1.8k 1.6× 1.1k 1.9× 128 5.5k
Bernd H. Belohradsky 1.2k 0.5× 2.4k 1.1× 1.0k 0.5× 1.4k 1.3× 460 0.8× 98 5.1k
Julian Symons 872 0.4× 2.5k 1.1× 2.9k 1.5× 1.3k 1.2× 375 0.6× 102 7.4k
Howard M. Lederman 1.1k 0.5× 2.8k 1.3× 1.5k 0.7× 1.8k 1.6× 575 1.0× 137 6.5k
Kai Krohn 1.8k 0.8× 2.3k 1.1× 1.1k 0.5× 1.2k 1.1× 394 0.7× 177 6.9k
Raffaele Badolato 865 0.4× 3.2k 1.5× 857 0.4× 1.2k 1.1× 482 0.8× 165 6.0k
Reinhard Seger 1.6k 0.7× 4.8k 2.2× 1.4k 0.7× 2.0k 1.8× 402 0.7× 141 7.8k
Kathrin S. Michelsen 900 0.4× 4.0k 1.8× 1.2k 0.6× 1.9k 1.7× 812 1.4× 64 6.8k
Jerry A. Winkelstein 1.3k 0.6× 3.5k 1.6× 1.5k 0.8× 1.0k 0.9× 955 1.6× 112 7.1k
Christoph Mueller 1.2k 0.5× 3.6k 1.6× 882 0.5× 1.8k 1.7× 1.0k 1.8× 145 6.9k

Countries citing papers authored by Stéphane Paul

Since Specialization
Citations

This map shows the geographic impact of Stéphane Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Paul more than expected).

Fields of papers citing papers by Stéphane Paul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Paul. The network helps show where Stéphane Paul may publish in the future.

Co-authorship network of co-authors of Stéphane Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Paul. A scholar is included among the top collaborators of Stéphane Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Paul. Stéphane Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sinha, Divya, et al.. (2025). A user’s guide to designing efficient and safe mucosal vaccines: Challenges & potentials. PubMed. 6(1). iqaf007–iqaf007.
2.
Heberden, Christine, Stanislas Mondot, Laurent Naudon, et al.. (2025). Anorexia nervosa symptoms are induced after specific gut microbiota dysbiosis transfer in germ-free mice. Gut Microbes. 17(1). 2563701–2563701.
3.
Pizzorno, Andrés, Aurélien Traversier, Bruno Pozzetto, et al.. (2024). Impaired mucosal IgA response in patients with severe COVID-19. Emerging Microbes & Infections. 13(1). 2401940–2401940. 2 indexed citations
4.
Chamorro, Beatriz, Gokul Swaminathan, Egbert Mundt, & Stéphane Paul. (2023). Towards more translatable research: Exploring alternatives to gavage as the oral administration route of vaccines in rodents for improved animal welfare and human relevance. Lab Animal. 52(9). 195–197. 6 indexed citations
5.
Roblin, Xavier, Stéphane Nancey, Konstantinos Papamichael, et al.. (2023). Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 18(5). 679–685. 18 indexed citations
6.
Roblin, Xavier, et al.. (2023). Tu1762 RISANKIZUMAB LEVELS ARE SIGNIFICANTLY CORRELATED AND PREDICTIVE OF BIOMARKER REMISSION IN CROHN'S DISEASE. Gastroenterology. 164(6). S–1114. 1 indexed citations
7.
Fuméry, Mathurin, Stéphane Nancey, Jérôme Filippi, et al.. (2023). Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study. Alimentary Pharmacology & Therapeutics. 57(11). 1290–1298. 2 indexed citations
8.
Berger, Anne‐Emmanuelle, et al.. (2023). Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection. Vaccines. 11(4). 773–773. 2 indexed citations
9.
Moritz, Christian P., Yannick Tholance, Le Duy, et al.. (2023). Anti-AGO1 Antibodies Identify a Subset of Autoimmune Sensory Neuronopathy. Neurology Neuroimmunology & Neuroinflammation. 10(3). 11 indexed citations
10.
Duru, G., Stéphane Nancey, Jean–Marc Phelip, et al.. (2023). P325 Proton pump inhibitors are associated with a disabling course of Crohn’s disease. Journal of Crohn s and Colitis. 17(Supplement_1). i464–i465. 1 indexed citations
11.
Cathébras, P., Xavier Roblin, Damien Thibaudin, et al.. (2021). Immunomonitoring du rituximab appliqué aux maladies auto-immunes : une aide pour la pratique clinique ?. La Revue de Médecine Interne. 42(6). 384–391.
12.
Killian, Martin, Sébastien Viel, Émilie Chalayer, et al.. (2021). JAK1/2 Inhibition in Severe TAFRO Syndrome: A Case Report. Annals of Internal Medicine. 174(5). 719–721. 10 indexed citations
13.
Williet, Nicolas, Lieven Pouillon, Manoel de Carvalho, et al.. (2018). Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study. Alimentary Pharmacology & Therapeutics. 47(7). 906–912. 87 indexed citations
14.
Roblin, Xavier, Gilles Boschetti, Nicolas Williet, et al.. (2017). Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial. Alimentary Pharmacology & Therapeutics. 46(2). 142–149. 89 indexed citations
15.
Gutjahr, Alice, et al.. (2016). Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting. Vaccines. 4(4). 34–34. 106 indexed citations
16.
Pavot, Vincent, Nicolas Rochereau, Julien Rességuier, et al.. (2014). Cutting Edge: New Chimeric NOD2/TLR2 Adjuvant Drastically Increases Vaccine Immunogenicity. The Journal of Immunology. 193(12). 5781–5785. 59 indexed citations
17.
Climent, Núria, Vincent Pavot, Felipe García, et al.. (2014). Co-delivery of Antigen p24 and NOD-ligands by PLA Nanoparticles to Human Dendritic Cells Promote Highly Functional HIV-1-Specific T-cell Responses. AIDS Research and Human Retroviruses. 30(S1). A240–A241. 1 indexed citations
18.
Gigante, Marc, Guorong Li, Céline Ferlay, et al.. (2012). Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.. PubMed. 32(12). 5447–51. 21 indexed citations
19.
Hernández, Juan C., et al.. (2011). Up-Regulation of TLR2 and TLR4 in Dendritic Cells in Response to HIV Type 1 and Coinfection with Opportunistic Pathogens. AIDS Research and Human Retroviruses. 27(10). 1099–1109. 44 indexed citations
20.
Paul, Stéphane, Michel Geist, David Snary, et al.. (2007). Specific Tumor Cell Targeting by a Recombinant MVA Expressing a Functional Single Chain Antibody on the Surface of Intracellular Mature Virus (IMV) Particles. Viral Immunology. 20(4). 664–672. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miles Parkes Breakdown of academic impact, for papers by Bernd H. Belohradsky Breakdown of academic impact, for papers by Julian Symons Breakdown of academic impact, for papers by Howard M. Lederman Breakdown of academic impact, for papers by Kai Krohn Breakdown of academic impact, for papers by Raffaele Badolato Breakdown of academic impact, for papers by Reinhard Seger Breakdown of academic impact, for papers by Kathrin S. Michelsen Breakdown of academic impact, for papers by Jerry A. Winkelstein Breakdown of academic impact, for papers by Christoph Mueller
Rankless by CCL
2026